Related Experiment Video

Updated: May 6, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K

Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention

Juan Luis Gutiérrez-Chico1, Julinda Mehilli

  • 1Munich University Clinic, Cardiology Department, Ludwig-Maximilian University, Marchioninistraße 15, 81377, Munich, DE, Germany.

Drugs
|October 25, 2013
PubMed

Insights

Women with coronary artery disease (CAD) show unique responses to treatments. While generally benefiting from antithrombotic drugs, they face higher bleeding risks, highlighting the need for gender-specific dosing guidelines.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Coronary artery disease (CAD) epidemiology and patient profiles differ significantly between women and men.
  • Women are often underrepresented in clinical trials, limiting understanding of cardiovascular therapy efficacy in this population.
  • Existing antiplatelet and anticoagulant therapies are generally effective in both sexes, but women may experience greater relative benefits.

Purpose of the Study:

  • To analyze gender-specific differences in the efficacy and safety of antithrombotic treatments for coronary artery disease (CAD).
  • To investigate the implications of differing risk profiles and clinical trial participation on treatment outcomes for women with CAD.
  • To address the unmet need for gender-based dosage guidelines for antithrombotic drugs in cardiology.

Main Methods:

  • Review of epidemiological data on CAD in women versus men.
  • Analysis of clinical trial data regarding the efficacy of antiplatelet and anticoagulant medications.
  • Examination of bleeding complication rates and potential causes, including dosage issues, in female cardiac patients.

Main Results:

  • Women with CAD, often older with poorer risk profiles, show a high relative benefit from antithrombotic drugs, especially with interventional treatment.
  • No gender-based differences were observed in reducing thromboembolic risk with potent antithrombotic agents.
  • Women consistently exhibit a higher incidence of bleeding complications, potentially due to more frequent over-dosage of antithrombotic treatments.

Conclusions:

  • Women with CAD represent a subgroup that could significantly benefit from optimized, gender-specific dosing of antithrombotic drugs.
  • The higher relative benefit observed in women underscores the importance of tailored therapeutic approaches.
  • The development and implementation of gender-based dosage guidelines are crucial unmet needs in the management of cardiovascular disease.

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.0K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762